Your BMI is lying to you, the metabolic problem nobody's talking about.
You look fine. Your weight's "normal." But your blood work tells a different story. Here's why South Asians play by different metabolic rules — and what to do about it.
Here's a scenario that plays out in GP clinics across Australia and New Zealand every week. A South Asian bloke in his late 30s comes in for a routine check. His BMI is 24 — technically normal. He doesn't look overweight. He's probably been told he's "fine" at every check-up he's ever had.
Then the bloods come back. Fasting glucose is creeping up. Triglycerides are high. HDL is low. Fasting insulin is elevated. His liver enzymes are borderline. He's on a trajectory toward type 2 diabetes and cardiovascular disease — and nobody flagged it because he doesn't look like someone at risk.
South Asians are at increased risk for developing type 2 diabetes and cardiovascular disease at lower BMI compared to other ancestral groups, and this increased risk is seen at younger ages. This isn't a marginal difference. South Asians are up to six times more likely to develop type 2 diabetes than the general population. 25% of heart attacks in this demographic occur under age 40, and 50% under age 50.
If you're of Indian, Sri Lankan, Pakistani, Bangladeshi, or Nepali descent — and particularly if you're living in Australia or New Zealand — this article is the blood test conversation your GP probably hasn't had with you yet.
The Rules Are Different
The standard BMI thresholds used in Australian general practice were developed primarily from European population data. For a Caucasian bloke, "overweight" starts at a BMI of 25 and "obese" at 30. For South Asians, those thresholds are clinically meaningless.
The WHO and multiple international consensus groups now recommend lower cutoffs for South Asian populations: normal weight is 18.5–22.9, overweight starts at 23, and obesity at 25. That means a South Asian man with a BMI of 26 — who'd be classified as mildly overweight by standard criteria — is already in the obese-equivalent risk category for his population.
The waist circumference thresholds are tighter too: 90cm for South Asian men (versus 102cm for European men) and 80cm for South Asian women (versus 88cm). If your GP is using the standard European cutoffs, your metabolic risk is being systematically underestimated.
The Thin-Fat Paradox
This is the biological reality that makes standard screening fail. South Asians frequently exhibit what researchers call the "thin-fat phenotype" — a body composition pattern where someone appears lean or normal weight externally but carries disproportionate visceral fat internally.
The key characteristics: higher total body fat percentage at the same BMI as a Caucasian person, lower skeletal muscle mass (which reduces insulin sensitivity and metabolic rate), increased visceral fat packed around the abdominal organs even when the belly doesn't look particularly large, and ectopic fat deposited in the liver, pancreas, and muscle tissue.
This pattern shows up remarkably early. MRI studies have found that even South Asian newborns demonstrate increased central adiposity compared to European newborns — suggesting the phenotype is partially programmed before birth.
The practical implication: a bloke who looks like a BMI of 23 on the outside can be metabolically equivalent to a BMI of 28 on the inside. His risk of insulin resistance, fatty liver, and cardiovascular disease is being driven by fat you can't see and a scale won't detect.
Why: The Evolutionary Backstory
There are two leading hypotheses, and they're not mutually exclusive.
The thrifty genotype hypothesis proposes that populations exposed to repeated cycles of famine — and the Indian subcontinent has a long, well-documented history of severe famines — developed genetic adaptations that favour efficient energy storage. Genes that helped your ancestors survive periods of starvation by rapidly storing fat when food was available and conserving energy during lean times were powerfully selected for. In a modern environment of caloric abundance and sedentary living, those same adaptations promote excessive fat storage and insulin resistance. The survival advantage became a metabolic liability.
The adipose tissue overflow hypothesis explains why the problems hit at lower body weight. South Asians appear to have a constitutionally smaller subcutaneous fat storage compartment — the "safe" fat layer under the skin. When energy intake exceeds what this compartment can hold, excess fat overflows into the visceral compartment (around the organs) and into ectopic sites (liver, pancreas, muscle). Because the overflow threshold is reached earlier, metabolic dysfunction develops at lower absolute fat mass than in European populations.
Think of it like two different-sized fuel tanks. Both populations are filling up at the same rate, but one tank is smaller — so it overflows sooner, and the spillage goes to the places that cause the most damage.
What This Means for Your Health Checks
If you're South Asian and living in Australia or New Zealand, here's what a properly calibrated assessment should include:
Waist circumference using South Asian-specific cutoffs — 90cm for men, 80cm for women. This is more predictive of cardiometabolic risk than BMI in your population. Ask your GP to measure it and record it using the correct thresholds.
Fasting insulin alongside fasting glucose and HbA1c. Standard glucose screening misses the early stages of insulin resistance, which is the metabolic engine driving the entire syndrome. Fasting insulin and HOMA-IR (a calculated measure of insulin resistance) catch the problem years earlier.
A full lipid profile including triglycerides. The characteristic South Asian dyslipidaemia pattern is high triglycerides, low HDL, and elevated small dense LDL particles — which is a more atherogenic profile than just having a high total cholesterol number.
Liver function tests and consider a liver ultrasound. Non-alcoholic fatty liver disease develops at lower BMI thresholds in South Asians and is both a marker and a driver of metabolic dysfunction.
Body composition assessment if available. A DEXA scan quantifies visceral fat, body fat percentage, and lean mass — giving you the full picture that BMI can't. Not every GP clinic has access, but it's increasingly available in Australia through preventive health clinics.
What to Do About It
The good news is that the same interventions that work for metabolic syndrome in any population work here — they just need to start earlier and be applied at lower thresholds.
Resistance training is non-negotiable. Lower baseline muscle mass is one of the key drivers of South Asian metabolic vulnerability. Research has found that South Asians have lower lean muscle mass compared to other populations, contributing to adverse body composition. Diabetes Journals But the capacity to build muscle is the same — studies show South Asians have similar muscle protein synthesis rates and adaptive responses to resistance training as European populations. The deficit is starting point, not potential. Two to three sessions per week of progressive resistance training is the single most impactful intervention for improving insulin sensitivity, increasing metabolic rate, and shifting body composition.
Dietary pattern matters more than calorie counting. Research has identified that a dietary pattern rich in fruits, vegetables, nuts, and legumes is associated with lower rates of hypertension and metabolic syndrome in South Asians, while a pattern heavy in fried snacks, sweets, and high-fat dairy is associated with higher insulin resistance and worse lipid profiles. Diabetes Journals The traditional South Asian diet isn't inherently unhealthy — it depends entirely on which version you're eating. A dal-and-vegetable-heavy pattern is protective. A paratha-and-mithai-heavy pattern is not. The adaptation isn't about abandoning your cuisine; it's about shifting the balance within it.
Aerobic exercise for visceral fat reduction. Minimum 150 minutes per week of moderate intensity — walking, cycling, swimming. Visceral fat is preferentially responsive to aerobic exercise, and the metabolic benefits show up even before significant weight loss occurs on the scale.
Get screened earlier and more often. If you have a family history of diabetes or heart disease, metabolic screening should start in your 20s or early 30s — not at 45 when Australian general practice guidelines typically kick in. Ask for it proactively.
Consider pharmacological support when lifestyle alone isn't enough. GLP-1 receptor agonists (semaglutide, tirzepatide) are particularly effective for visceral fat reduction and may be considered even at lower BMI when body composition assessment reveals metabolic obesity. Metformin remains first-line for prediabetes and established insulin resistance.
The Two-Minute Version
South Asians develop metabolic syndrome, type 2 diabetes, and cardiovascular disease at lower body weights and younger ages than European populations. Standard BMI thresholds systematically underestimate risk. The thin-fat phenotype means you can look lean and be metabolically unhealthy.
The fix: use population-specific screening cutoffs, test fasting insulin alongside glucose, prioritise resistance training to address the muscle mass deficit, shift dietary patterns within your own cuisine, and don't wait until you're 45 to get screened.
Your BMI might say you're fine. Your metabolism might disagree. Find out which one's telling the truth.